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Background
Asthmatic individuals respond differently, but reproduci-
bly, to allergen inhalation challenge. Some individuals
develop an isolated early response (ER), while others
develop a dual response (DR). Peripheral blood cell tran-
scriptome signatures can discriminate isolated early
responders from dual asthmatic responders undergoing
allergen inhalation challenge.
Methods
35 individuals (17 ERs and 18 DRs) participated in the
allergen inhalation challenge. Blood samples were
obtained prior to and 2 hours post allergen inhalation
challenge. HiSeq-Illumina paired-ends 100bp sequencing
was performed. A UCSC transcriptome using both the
UCSC gene and gene-isoform transcripts was created
using the RSEM (RNA-Seq by Expectation Maximiza-
tion) package. RSEM uses Bowtie to align read files to
the reference transcripts and estimates the expected
number of counts per transcript. The biomarker pipeline
consisted of 20x5-fold deep cross-validation using limma
voom (linear models for microarrays and RNA-Seq
using variance modeling at the observational level) for
differential expression and elastic net for classification.
Gene set enrichment analysis was performed using
GeneGo.
Results
Classification performance of the pre-challenge classifier
across the 100 panels included an AUC of 0.76±0.02, a
sensitivity of 0.70±0.03 and a specificity of 0.72±0.02.
There were 511 gene transcripts identified across the
100 panels. Pathway analysis of the 511 gene transcripts
identified lectin induced complement pathway, integrin
inside-out signaling, alternative complement pathway
and function of MEF2 in T lymphocytes as the top
ranked pathways. Classification performance of the post-
challenge classifier across the 100 panels included an
AUC of 0.62±0.002, a sensitivity of 0.67±0.002 and a
specificity of 0.54±0.003. There were 301 gene tran-
scripts identified across the 100 panels. Pathway analysis
of the 301 gene transcripts identified clathrin coated
vesicles formation, CDC42 in cellular processes and reg-
ulation of actin cytoskeleton by Rho GTPases as the top
ranked pathways.
Conclusion
The pre-challenge classifier out-performed the post-
challenge classifier in the internal deep cross-validation
as depicted by the classification performance measures.
The lower performance of the post-challenge classifier
in discriminating ERs from DRs may be due to a dilu-
tion of signal, given that both responder groups are
undergoing an immune response to allergen inhalation.
Incorporating changes in cellular composition and gene
isoform expression estimates may improve classification
performance and also reveal new insights into the
mechanisms of the late phase asthmatic response.
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